Literature DB >> 16831566

Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies.

Hiroko Iijima1, Fuminori Moriyasu, Takeo Miyahara, Kyosuke Yanagisawa.   

Abstract

Phase contrast microscopy showed that Levovist microbubbles were phagocytosed by cultured Kupffer cells and moved gradually toward the nucleus from the cell surface. They were diminished in size and disappeared within 30min by diffusion of the gas contained within the microbubbles. In an in vivo study, confocal laser scanning microscopy demonstrated that Levovist microbubbles were trapped and phagocytosed by Kupffer cells. No microbubbles were observed attached to the sinusoidal endothelium. Our findings suggest that liver-specific images obtained following intravenous injection of Levovist are composed of signals from microbubbles phagocytosed by Kupffer cells.

Entities:  

Year:  2006        PMID: 16831566     DOI: 10.1016/j.hepres.2006.04.016

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  Liquid Flooded Flow-Focusing Microfluidic Device for in situ Generation of Monodisperse Microbubbles.

Authors:  Ali Haider Dhanaliwala; Johnny L Chen; Shiying Wang; John A Hossack
Journal:  Microfluid Nanofluidics       Date:  2012-10-06       Impact factor: 2.529

Review 2.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

3.  Diagnosis of liver cirrhosis with contrast-enhanced ultrasound.

Authors:  Guang-Jian Liu; Ming-De Lu
Journal:  World J Radiol       Date:  2010-01-28

4.  Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Toshiko Hirai; Hajime Ohishi; Mitsuteru Kitade; Hitoshi Yoshiji; Masahito Uemura; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

5.  Synthesis and characterization of transiently stable albumin-coated microbubbles via a flow-focusing microfluidic device.

Authors:  Johnny L Chen; Ali H Dhanaliwala; Adam J Dixon; Alexander L Klibanov; John A Hossack
Journal:  Ultrasound Med Biol       Date:  2013-12-15       Impact factor: 2.998

6.  Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies.

Authors:  Samantha M Fix; A Gloria Nyankima; Morgan D McSweeney; James K Tsuruta; Samuel K Lai; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2018-03-27       Impact factor: 2.998

7.  Enhanced intracellular delivery of a model drug using microbubbles produced by a microfluidic device.

Authors:  Adam J Dixon; Ali H Dhanaliwala; Johnny L Chen; John A Hossack
Journal:  Ultrasound Med Biol       Date:  2013-04-30       Impact factor: 2.998

Review 8.  Nonalcoholic fatty liver disease: a review and update.

Authors:  Jeffrey R Lewis; Smruti R Mohanty
Journal:  Dig Dis Sci       Date:  2010-01-26       Impact factor: 3.199

Review 9.  Diagnosis and evaluation of nonalcoholic fatty liver disease.

Authors:  Mikako Obika; Hirofumi Noguchi
Journal:  Exp Diabetes Res       Date:  2011-10-27

10.  Grey scale enhancement by a new self-made contrast agent in early cirrhotic stage of rabbit liver.

Authors:  Li Zhang; Yun-You Duan; Ji-Kai Yin; Ji-Hong Cui; Yong Zhang; Tie-Sheng Cao
Journal:  BMC Gastroenterol       Date:  2007-08-08       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.